Tumor Microenvironment composition and severe cytokine release syndrome (CRS) Influence Toxicity in Patients with Large B Cell Lymphoma Treated with Axicabtagene Ciloleucel

PURPOSE: One of the challenges of adoptive T cell therapy is the development of immune mediated toxicities including cytokine release syndrome (CRS) and neurotoxicity (NT). We aimed to identify factors that place patients at high risk of severe toxicity or treatment related death in a cohort of 75 p...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Clin Cancer Res
المؤلفون الرئيسيون: Faramand, Rawan, Jain, Michael, Staedtke, Verena, Kotani, Hiroshi, Bai, Renyuan, Reid, Kayla, Lee, Sae Bom, Spitler, Kristen, Wang, Xuefeng, Cao, Biwei, Pinilla, Javier, Lazaryan, Aleksander, Khimani, Farhad, Shah, Bijal, Chavez, Julio C., Nishihori, Taiga, Mishra, Asmita, Mullinax, John, Gonzalez, Ricardo, Hussaini, Mohammad, Dam, Marian, Brandjes, Brigett D, Bachmeier, Christina A, Anasetti, Claudio, Locke, Frederick L., Davila, Marco L.
التنسيق: Artigo
اللغة:Inglês
منشور في: 2020
الموضوعات:
Article
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC7501265/
https://ncbi.nlm.nih.gov/pubmed/32669372
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-20-1434
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة